Phathom Pharmaceuticals Inc. (PHAT)
PHAT trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$7.00
-1.82% on the day
Market cap
$566.3M
Small cap
Revenue · 2025
$175.1M
+216.9% on 2024
Net income · 2025
-$221K
-0.1% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | PHAT on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2019 |
| SEC CIK | 0001783183 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $175.1M |
| Net income | -$221K |
| Operating income | -$160.0M |
| Net margin | -0.1% |
| Operating margin | -91.4% |
| Revenue growth | +216.9% |
| Cash | $130.0M |
| Total assets | $259.1M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 3.2× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-01-08 |
| Latest annual report | 10-K | 2026-02-26 |
| Latest quarterly / interim | 10-Q | 2026-07-30 |
| Latest current report | 8-K | 2026-09-29 |
| Latest proxy | DEFA14A | 2026-04-07 |
Source: SEC EDGAR submissions feed, 490 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +10.5% |
| 1 month | -7.8% |
| 3 months | -31.4% |
| Year to date | -54.6% |
| 1 year | -39.9% |
| From 52-week high | -58.4% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SGMT | Sagimet Biosciences Inc. Series A | $7.98 | -9.32% | $562.9M |
| CRMD | CorMedix Inc. | $7.39 | -0.94% | $576.0M |
| FTH | Faeth Therapeutics Inc. | $21.51 | -7.48% | $555.8M |
| SLN | Silence Therapeutics Plc American Depository Share | $8.87 | -8.08% | $551.3M |
| STTK | Shattuck Labs Inc. | $5.49 | -9.85% | $551.0M |
| AQST | Aquestive Therapeutics Inc. | $4.67 | -2.91% | $586.1M |
| NVCT | Nuvectis Pharma Inc. | $18.15 | -7.82% | $591.9M |
| CLYM | Climb Bio Inc. | $10.31 | -4.80% | $592.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier